Lantern Pharma Inc. (NASDAQ:LTRN) Q2 2023 Earnings Call Transcript

Lantern Pharma Inc. (NASDAQ:LTRN) Q2 2023 Earnings Call Transcript August 9, 2023

Lantern Pharma Inc. misses on earnings expectations. Reported EPS is $-0.44 EPS, expectations were $-0.4.

Nicole Leber: Good afternoon, everyone. I’m Nicole Leber with Investor Relations here at Lantern Pharma. Welcome to our Second Quarter 2023 Earnings Call. I will be your host for today’s call. As a reminder, this call is being recorded and all attendees are in a listen-only mode. We will open up the...